BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1332066)

  • 1. Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.
    Murty VV; Houldsworth J; Baldwin S; Reuter V; Hunziker W; Besmer P; Bosl G; Chaganti RS
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11006-10. PubMed ID: 1332066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic changes in human male germ cell tumors.
    Lothe RA; Peltomäki P; Tommerup N; Fosså SD; Stenwig AE; Børresen AL; Nesland JM
    Lab Invest; 1995 Nov; 73(5):606-14. PubMed ID: 7474934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification.
    Samaniego F; Rodriguez E; Houldsworth J; Murty VV; Ladanyi M; Lele KP; Chen QG; Dmitrovsky E; Geller NL; Reuter V
    Genes Chromosomes Cancer; 1990 Mar; 1(4):289-300. PubMed ID: 2177638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
    Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
    Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic aspects of pediatric germ cell tumors].
    Stock C; Ambros IM; Strehl S; Zoubek A; Fink FM; Gadner H; Ambros PF
    Klin Padiatr; 1995; 207(4):235-41. PubMed ID: 7564160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
    Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
    Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells.
    Geurts van Kessel A; van Drunen E; de Jong B; Oosterhuis JW; Langeveld A; Mulder MP
    Cancer Genet Cytogenet; 1989 Jul; 40(1):129-34. PubMed ID: 2569358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity of tumor suppressor genes in testis cancer.
    Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
    Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors.
    al-Jehani RM; Povey S; Delhanty JD; Parrington JM
    Genes Chromosomes Cancer; 1995 Aug; 13(4):249-56. PubMed ID: 7547632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of the i(12p) marker chromosome in germ cell tumors.
    Bosl GJ; Ilson DH; Rodriguez E; Motzer RJ; Reuter VE; Chaganti RS
    J Natl Cancer Inst; 1994 Mar; 86(5):349-55. PubMed ID: 8308927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on testicular germ cell neoplasms.
    Cheng L; Lyu B; Roth LM
    Hum Pathol; 2017 Jan; 59():10-25. PubMed ID: 27569298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. i(12p)-negative testicular germ cell tumors. A different group?
    Castedo SM; de Jong B; Oosterhuis JW; Seruca R; Idenburg VJ; Buist J; Sleijfer DT
    Cancer Genet Cytogenet; 1988 Oct; 35(2):171-8. PubMed ID: 2846146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of loss of heterozygosity with cytogenetic analysis using G-banding and fluorescence in situ hybridization in aneuploid cultures from two human testicular germ-cell tumors.
    al-Jehani RM; Wells D; Fox M; Parrington JM
    Cancer Genet Cytogenet; 1995 Nov; 85(1):26-36. PubMed ID: 8536234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines.
    Murty VV; Dmitrovsky E; Bosl GJ; Chaganti RS
    Cancer Genet Cytogenet; 1990 Nov; 50(1):67-73. PubMed ID: 2253191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic perspective of male germ cell tumors.
    Murty VV; Chaganti RS
    Semin Oncol; 1998 Apr; 25(2):133-44. PubMed ID: 9562446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors.
    Sandberg AA; Meloni AM; Suijkerbuijk RF
    J Urol; 1996 May; 155(5):1531-56. PubMed ID: 8627820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of isochromosome 12p and identification of other chromosome 12 aberrations in gonadal and extragonadal human germ cell tumors by bicolor double fluorescence in situ hybridization.
    Suijkerbuijk RF; Looijenga L; de Jong B; Oosterhuis JW; Cassiman JJ; Geurts van Kessel A
    Cancer Genet Cytogenet; 1992 Oct; 63(1):8-16. PubMed ID: 1330288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human testicular cancer. Changes in autosomal dosage.
    Peltomäki P; Halme A; de la Chapelle A
    Cancer Genet Cytogenet; 1990 Aug; 48(1):1-12. PubMed ID: 1973631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.